Are there Gender Specific Differences in Patient Characteristics at Initiation of Biologic Treatment in Rheumatoid Arthritis?

被引：0
|
作者：
Bensen, William [1 ]
Choquette, Denis [2 ]
Fortin, Isabelle [3 ]
Klinkhoff, Alice [4 ]
Rampalcakis, Emmanouil [5 ,6 ]
Sampalis, John [7 ,8 ]
Shawi, May [9 ]
Lehman, Allen [9 ]
Otawa, Susan [9 ]
机构：
[1] McMaster Univ, St Josephs Hosp, Rheumatol Hlth Team, Hamilton, ON L8S 4L8, Canada
[2] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[3] Ctr Sante & Serv Sociaux Rimousk, Rimouski, PQ, Canada
[4] Mary Pack Arthrit Program, Vancouver, BC, Canada
[5] JSS Med Res, St Laurent, PQ, Canada
[6] McGill Univ, St Laurent, PQ, Canada
[7] McGill Univ, Westmount, PQ, Canada
[8] Univ Montreal, Westmount, PQ, Canada
[9] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
187
引用
收藏
页码：1020 / 1021
页数：2
相关论文
共 50 条
  • [41] Additions to Methotrexate with Conventional and Biologic Dmards in Rheumatoid Arthritis: Are There Differences in Subsequent Time to Treatment Failure?
    Bernatsky, Sasha
    Schieir, Orit
    Moura, Cristiano S.
    Valois, Marie-France
    Bartlett, Susan J.
    Hitchon, Carol A.
    Pope, Janet E.
    Boire, Gilles
    Haraoui, Boulos
    Keystone, Edward C.
    Tin, Diane
    Thorne, Carter
    Bykerk, Vivian P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [42] Preferences for treatment with biologic agents in rheumatoid arthritis (RA).
    Constantinescu, Florina
    Wani, Shoba
    Gaucher, Susan
    Weinstein, Arthur
    Fraenkel, Liana
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4096 - 4096
  • [43] Biologic therapies in clinical development for the treatment of rheumatoid arthritis
    Genovese, MC
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (03) : S45 - S54
  • [44] INDIRECT TREATMENT COMPARISONS OF BIOLOGIC THERAPIES FOR RHEUMATOID ARTHRITIS
    Alfonso, R.
    Devine, B.
    Sullivan, S. D.
    VALUE IN HEALTH, 2010, 13 (03) : A136 - A136
  • [45] PERSISTENCE WITH BIOLOGIC AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN JAPAN
    Mahlich, J. C.
    Sruamsiri, R.
    VALUE IN HEALTH, 2016, 19 (07) : A918 - A918
  • [46] Cost of Biologic Treatment Persistence or Switching in Rheumatoid Arthritis
    Gu, Tao
    Mutebi, Alex
    Stolshek, Bradley S.
    Tan, Hiangkiat
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : SP338 - SP345
  • [47] THE USE OF BIOLOGIC DRUGS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN ITALY
    Heiman, F.
    Katz, P.
    Pegoraro, V
    Di Virgilio, R.
    VALUE IN HEALTH, 2013, 16 (07) : A557 - A557
  • [48] Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
    Mahlich, Joerg
    Sruamsiri, Rosarin
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 1509 - 1518
  • [49] ETHNICITY IS ASSOCIATED WITH BIOLOGIC TREATMENT PERSISTENCE IN RHEUMATOID ARTHRITIS
    Kumar, K.
    Sahbudin, I.
    Filer, A.
    Buckley, C. D.
    Raza, K.
    Stack, R.
    Nightingale, P.
    Deeming, A.
    Situnayake, D.
    de Pablo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 483 - 483
  • [50] An Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic Naive Rheumatoid Arthritis Patients
    Kottak, Nicholas
    Rosenberg, Melissa
    Parenti, Dennis
    Kafka, Shelly
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345